Bausch Health Companies Inc $ 28.4 -0.79 (-2.71%)
Volume:
4,808,602
Avg Vol (1m):
3,634,782
Market Cap $:
10.02 Bil
Enterprise Value $:
33.14 Bil
P/E (TTM):
0.00
P/B:
4.00
Financial Strength | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.04 | ||
| Equity-to-Asset | 0.08 | ||
| Debt-to-Equity | 9.5 | ||
| Debt-to-EBITDA | 7.88 | ||
| Interest Coverage | 0.75 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 0.32 | ||
| Beneish M-Score | -2.86 | ||
| WACC vs ROIC | |||
Profitability Rank | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 14.49 | ||
| Net Margin % | -7.27 | ||
| ROE % | -22.73 | ||
| ROA % | -1.91 | ||
| ROC (Joel Greenblatt) % | 62.04 | ||
| 3-Year Revenue Growth Rate | -8.5 | ||
| 3-Year EBITDA Growth Rate | -55.8 | ||
| 3-Year EPS without NRI Growth Rate | -138.8 |
Valuation Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 6.03 | ||
| Price-to-Owner-Earnings | 14.37 | ||
| PB Ratio | 4 | ||
| PS Ratio | 1.16 | ||
| Price-to-Free-Cash-Flow | 7.41 | ||
| Price-to-Operating-Cash-Flow | 6.21 | ||
| EV-to-EBIT | 38.73 | ||
| EV-to-EBITDA | 10.95 | ||
| EV-to-Revenue | 3.83 | ||
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.86 | ||
| Days Inventory | 159.23 | ||
| Days Sales Outstanding | 74.52 | ||
| Days Payable | 68.36 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.57 | ||
| Price-to-Median-PS-Value | 0.35 | ||
| Earnings Yield (Greenblatt) % | 2.58 | ||
| Forward Rate of Return (Yacktman) % | -8.28 |